Company · CIK 1650648
4D Molecular Therapeutics, Inc.
| CIK | 1650648 (SEC EDGAR) |
|---|---|
| Industry (SIC) | 2836 — Biological Products, (No Diagnostic Substances) |
| Incorporated in | DE |
| Business address | CA |
| Listed | FDMT (Nasdaq) |
| First annual or quarterly report | 2021-03-25 |
Offerings
8 registrations| Registration | Label and status | First filed | Last event | Filings |
|---|---|---|---|---|
| 333-295650 | 2026-05-07 | 2026-05-13 | 2 | |
| 333-273845 | 2023-08-09 | 2025-11-06 | 3 | |
| 333-276872 | 2024-02-05 | 2025-03-24 | 5 | |
| 333-263925 | 2022-03-29 | 2023-05-08 | 4 | |
| 333-267013 | 2022-08-23 | 2022-09-06 | 2 | |
| 333-260508 | 2021-10-26 | 2021-11-01 | 3 | |
| 333-250150 | 2020-11-17 | 2020-12-14 | 5 | |
| 333-234021 | 2019-09-30 | 2020-07-21 | 2 |
Filings
29| Filed | Filing | Registration | Accession |
|---|---|---|---|
| 2026-05-13 | EFFECTDeclared effective | 333-295650 | 9999999995-26-001626 |
| 2026-05-07 | S-3Shelf registered | 333-295650 | 0001193125-26-212323 |
| 2025-11-06 | 424B5Shelf takedown | 333-273845 | 0001193125-25-269700 |
| 2025-03-24 | EFFECTDeclared effective | 333-276872 | 9999999995-25-000737 |
| 2024-06-07 | 424B5Shelf takedown | 333-276872 | 0001193125-24-157513 |
| 2024-02-08 | 424B5Shelf takedown | 333-276872 | 0001193125-24-028376 |
| 2024-02-05 | 424B5Shelf takedown | 333-276872 | 0001193125-24-024196 |
| 2024-02-05 | S-3ASRShelf registered | 333-276872 | 0001193125-24-024104 |
| 2023-08-15 | EFFECTDeclared effective | 333-273845 | 9999999995-23-002401 |
| 2023-08-09 | S-3Shelf registered | 333-273845 | 0001193125-23-207470 |
| 2023-05-08 | 424B5Shelf takedown | 333-263925 | 0001193125-23-138372 |
| 2023-05-04 | 424B5Shelf takedown | 333-263925 | 0001193125-23-135977 |
| 2022-09-06 | EFFECTDeclared effective | 333-267013 | 9999999995-22-002599 |
| 2022-08-23 | S-3Shelf registered | 333-267013 | 0001193125-22-226652 |
| 2022-04-15 | EFFECTDeclared effective | 333-263925 | 9999999995-22-000994 |
| 2022-03-29 | S-3Shelf registered | 333-263925 | 0001193125-22-087325 |
| 2021-11-01 | 424B4Final prospectus | 333-260508 | 0001193125-21-315511 |
| 2021-10-28 | EFFECTDeclared effective | 333-260508 | 9999999995-21-004087 |
| 2021-10-26 | S-1Registration filed | 333-260508 | 0001193125-21-308105 |
| 2021-10-08 | DRSDraft made public | 377-05573 | 0000950123-21-012961 |
| 2020-12-14 | 424B4Final prospectus | 333-250150 | 0001193125-20-316117 |
| 2020-12-10 | EFFECTDeclared effective | 333-250150 | 9999999995-20-003479 |
| 2020-12-10 | S-1/AAmendment | 333-250150 | 0001193125-20-314317 |
| 2020-12-07 | S-1/AAmendment | 333-250150 | 0001193125-20-311111 |
| 2020-11-17 | S-1Registration filed | 333-250150 | 0001193125-20-296146 |
| 2020-10-14 | DRSDraft made public | 377-03669 | 0000950123-20-010265 |
| 2020-07-21 | RWWithdrawn | 333-234021 | 0001193125-20-196249 |
| 2019-09-30 | S-1Registration filed | 333-234021 | 0001193125-19-258924 |
| 2019-08-02 | DRSDraft made public | 377-02769 | 0000950123-19-006967 |